Javascript must be enabled to continue!
Graded and Pathway-Specific Integration of Insulin, Glucagon, and Time Shapes Hepatic Transcriptional Programs
View through CrossRef
Introduction: Insulin and glucagon are principal regulators of hepatic metabolism [1,2], yet their transcriptional effects are often examined using binary perturbation models that obscure graded and context-dependent regulation. Most studies contrast hormone presence versus absence, limiting resolution of dose-dependent and multivariate integration. This study aimed to determine how continuous variation in insulin and glucagon concentrations, together with incubation time, independently shapes hepatic transcriptional pathway activity.
Methodology: Primary mouse hepatocytes were exposed to multiple concentrations of insulin and glucagon across different incubation times. RNA sequencing was performed to quantify transcriptomes. Pathway activity was inferred using Gene Set Variation Analysis (GSVA) across all 50 Hallmark gene sets [3-4]. For each pathway, additive linear models were fitted to estimate independent contributions of log2-transformed insulin concentration, log2-transformed glucagon concentration, and incubation time. Effect sizes and adjusted R² values were used to assess pathway-specific regulation and relative contributions of hormonal and temporal effects.
Results & Discussion: Insulin emerged as the dominant hormonal regulator, exerting graded and pathway-specific effects rather than binary responses. Metabolic and anabolic pathways, including glycolysis, mTORC1 signaling, and cholesterol homeostasis, showed positive insulin-associated coefficients with variable effect sizes, indicating differential sensitivity to insulin concentration. In contrast, glucagon rarely exhibited strong independent main effects. When present, glucagon-associated coefficients were typically opposite in direction to insulin, consistent with antagonistic rather than synergistic regulation.
Only a limited subset of pathways-primarily central metabolic signaling hubs-showed strong contributions from both hormones, and these effects were predominantly antagonistic. No pathway demonstrated strong concordant regulation by insulin and glucagon. Incubation time was a major independent determinant of pathway activity. Cell cycle-and transcription-associated programs, including E2F, MYC, and G2M checkpoint pathways, were strongly time-dependent and frequently exceeded hormonal contributions, indicating progressive transcriptional adaptation during in vitro incubation.
Conclusion: Hepatic transcriptional pathway regulation reflects graded, pathway-specific insulin responsiveness, limited independent glucagon effects, and strong time-dependent adaptation. These findings demonstrate that endocrine integration at the pathway level cannot be fully captured by binary hormone perturbation designs and underscore the importance of continuous multivariate modeling approaches [5].
KVR Book Central
Title: Graded and Pathway-Specific Integration of Insulin, Glucagon, and Time Shapes Hepatic Transcriptional Programs
Description:
Introduction: Insulin and glucagon are principal regulators of hepatic metabolism [1,2], yet their transcriptional effects are often examined using binary perturbation models that obscure graded and context-dependent regulation.
Most studies contrast hormone presence versus absence, limiting resolution of dose-dependent and multivariate integration.
This study aimed to determine how continuous variation in insulin and glucagon concentrations, together with incubation time, independently shapes hepatic transcriptional pathway activity.
Methodology: Primary mouse hepatocytes were exposed to multiple concentrations of insulin and glucagon across different incubation times.
RNA sequencing was performed to quantify transcriptomes.
Pathway activity was inferred using Gene Set Variation Analysis (GSVA) across all 50 Hallmark gene sets [3-4].
For each pathway, additive linear models were fitted to estimate independent contributions of log2-transformed insulin concentration, log2-transformed glucagon concentration, and incubation time.
Effect sizes and adjusted R² values were used to assess pathway-specific regulation and relative contributions of hormonal and temporal effects.
Results & Discussion: Insulin emerged as the dominant hormonal regulator, exerting graded and pathway-specific effects rather than binary responses.
Metabolic and anabolic pathways, including glycolysis, mTORC1 signaling, and cholesterol homeostasis, showed positive insulin-associated coefficients with variable effect sizes, indicating differential sensitivity to insulin concentration.
In contrast, glucagon rarely exhibited strong independent main effects.
When present, glucagon-associated coefficients were typically opposite in direction to insulin, consistent with antagonistic rather than synergistic regulation.
Only a limited subset of pathways-primarily central metabolic signaling hubs-showed strong contributions from both hormones, and these effects were predominantly antagonistic.
No pathway demonstrated strong concordant regulation by insulin and glucagon.
Incubation time was a major independent determinant of pathway activity.
Cell cycle-and transcription-associated programs, including E2F, MYC, and G2M checkpoint pathways, were strongly time-dependent and frequently exceeded hormonal contributions, indicating progressive transcriptional adaptation during in vitro incubation.
Conclusion: Hepatic transcriptional pathway regulation reflects graded, pathway-specific insulin responsiveness, limited independent glucagon effects, and strong time-dependent adaptation.
These findings demonstrate that endocrine integration at the pathway level cannot be fully captured by binary hormone perturbation designs and underscore the importance of continuous multivariate modeling approaches [5].
Related Results
Postprandial Glucagon Action in the Human Brain
Postprandial Glucagon Action in the Human Brain
ABSTRACT
Aims
Elevated fasting glucagon is linked to hyperglycemia, but postprandial glucagon effects are less understood...
34-OR: Postprandial Glucagon Action in the Human Brain
34-OR: Postprandial Glucagon Action in the Human Brain
While elevated fasting glucagon is linked to hyperglycemia, the impact of postprandial changes in glucagon is less clear. Recent findings suggest potential metabolic benefits of ri...
Glucagon and Its Receptors in the Mammalian Heart
Glucagon and Its Receptors in the Mammalian Heart
Glucagon exerts effects on the mammalian heart. These effects include alterations in the force of contraction, beating rate, and changes in the cardiac conduction system axis. The ...
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract
Introduction
During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
Evidence against Pathway-Selective Hepatic Insulin Resistance in Mice
Evidence against Pathway-Selective Hepatic Insulin Resistance in Mice
Insulin suppresses hepatic glucose production and increases hepatic de novo lipogenesis (DNL). Paradoxically, hepatic DNL remains elevated in insulin-resistant subjects, leading to...
Glucoregulatory Mechanisms Following Hypophysectomy in Diabetic Dogs with Residual Insulin Secretion
Glucoregulatory Mechanisms Following Hypophysectomy in Diabetic Dogs with Residual Insulin Secretion
It is known that in pancreatectomized dogs completely deprived of insulin, hypophysectomy normalizes plasma glucagon and prevents ketoacidosis, but rarely normalizes glucose levels...
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
OBJECTIVE:
To introduce a rapid-acting human insulin analog, insulin lispro; to review its pharmacology, therapeutics, pharmacokinetics, dosing guidelines, adve...

